Episode
Author Interview - Professor Andrew Cope, 2026
- Podcast
- The IMID Forum
- Published
- Mar 5, 2026
- Duration seconds
- 1490
- Processing state
not_requested- Canonical source
- https://soundcloud.com/imidforum/author-interview-professor
Actions
POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/author-interview-professor-andrew-cope-2026/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-imid-forum-981476/author-interview-professor-andrew-cope-2026.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Andrew Cope from the Centre for Rheumatic Diseases, King’s College London, London, UK, as they discuss his recent paper ‘Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial’.